Extending beyond established cardiometabolic benefits of empagliflozin in type 2 diabetes: the evolving paradigm of glycemic variability

Journal of Diabetes and its Complications 2026

View at publisher

Authors: Dimitrios Patoulias, Emir M. Muzurović, Viviana Maggio, Manfredi Rizzo

DOI: 10.1016/j.jdiacomp.2026.109276

Cited by: 0

References: 18

Fields of Study & Subjects

Diabetes Treatment and Management Diabetes Management and Research Heart Failure Treatment and Management

References 18